Literature DB >> 2478457

Receptor binding-like specificity of two anti-cholera toxin monoclonal antibodies detected by latex agglutination immunoassay.

G P Lucas1, C L Cambiaso, J P Vaerman.   

Abstract

Six mouse monoclonal IgG antibodies (mAbs) reacting with the cholera toxin B-subunit (CT-B) were obtained from the spleen cells of mice immunized with CT. They were divided into two groups according to their different reactivities with CT in latex (Lx) agglutination. One group of two mAbs was called "non-repetitive" (NR) because they apparently recognized a single epitope on CT, which was unable to agglutinate Lx coated with these NRmAbs, in contrast with the other group of four mAbs that we called "repetitive" (RmAbs). The two NRmAbs, but not the four RmAbs, failed to react with CT when CT was bound first to its GM1-receptor. Thus, the NRmAbs seemed directed at an epitope close to the GM1-binding site of CT-B. These NRmAbs could represent valuable immunogenic candidates for anti-idiotypic immunization against CT and related enterotoxins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478457     DOI: 10.1016/0165-2478(89)90196-x

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  3 in total

1.  Characterization of an anti-idiotypic MoAb bearing an internal image of the receptor-binding epitope of cholera toxin.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

2.  An interspecies idiotope associated with the anti-cholera toxin response detected by a monoclonal auto-anti-idiotypic antibody.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Immunology       Date:  1993-03       Impact factor: 7.397

3.  Protection of rat intestine against cholera toxin challenge by monoclonal anti-idiotypic antibody immunization via enteral and parenteral routes.

Authors:  G P Lucas; C L Cambiaso; J P Vaerman
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.